Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Ajani J.,,"Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma",2005,Journal of Clinical Oncology,181,10.1200/JCO.2005.17.376,Belgium,Article,3000 Leuven,0,Journal,2-s2.0-24944465318
Louvet C.,,Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: Results of a GERCOR and GISCAD phase III trial,2005,Journal of Clinical Oncology,818,10.1200/JCO.2005.06.023,Italy,Article,Milan,0,Journal,2-s2.0-20644464360
Parkin D.,,"Global cancer statistics, 2002",2005,Ca-A Cancer Journal for Clinicians,16508,10.3322/canjclin.55.2.74,France,Review,Lyon,0,Journal,2-s2.0-14944385553
Lima C.,,Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate,2004,Journal of Clinical Oncology,521,10.1200/JCO.2004.12.082,United States,Article,New York,0,Journal,2-s2.0-4644327989
André T.,,"Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer",2004,New England Journal of Medicine,2645,10.1056/NEJMoa032709,France;France,Article,Paris;Paris,0,Journal,2-s2.0-2542615200
Ohtsu A.,,"Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan clinical oncology group study (JCOG9205)",2003,Journal of Clinical Oncology,385,10.1200/JCO.2003.04.130,Japan;Japan,Article,Matsuyama;Kashiwa,0,Journal,2-s2.0-18744373000
Berlin J.,,Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group trial E2297,2002,Journal of Clinical Oncology,655,10.1200/JCO.2002.11.149,United States,Article,Nashville,0,Journal,2-s2.0-0036682041
Bang Y.J.,,Docetaxel 75 mg/m<sup>2</sup> is active and well tolerated in patients with metastatic or recurrent gastric cancer: A phase II trial,2002,Japanese Journal of Clinical Oncology,100,10.1093/jjco/hyf057,South Korea,Article,Seoul,1,Journal,2-s2.0-0036654749
Ross P.,,"Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) with epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer",2002,Journal of Clinical Oncology,447,10.1200/JCO.2002.08.105,United Kingdom,Article,Sutton,0,Journal,2-s2.0-0037090686
Colucci G.,,"Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: A prospective, randomized phase III study of the Gruppo Oncologico dell'Italia Meridionale",2002,Cancer,411,10.1002/cncr.10323,Italy,Article,Bari,1,Journal,2-s2.0-0037083621
Constenla M.,,"Docetaxel, 5-fluorouracil, and leucovorin as treatment for advanced gastric cancer: Results of a phase II study",2002,Gastric Cancer,36,10.1007/s101200200025,Spain,Article,Pontevedra,1,Journal,2-s2.0-0036034746
Ridwelski K.,,Combination chemotherapy with docetaxel and cisplatin for locally advanced and metastatic gastric cancer,2001,Annals of Oncology,146,10.1023/A:1008328501128,Germany,Article,Magdeburg,1,Journal,2-s2.0-0035131823
Mavroudis D.,,Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF): A phase II trial,2000,American Journal of Clinical Oncology: Cancer Clinical Trials,87,10.1097/00000421-200008000-00005,Greece,Article,Heraklion,0,Journal,2-s2.0-0034449134
Graziano F.,,A phase II study of weekly docetaxel as salvage chemotherapy for advanced gastric cancer,2000,Annals of Oncology,84,10.1023/A:1008373814453,Italy,Article,Urbino,1,Journal,2-s2.0-0033758526
Roth A.D.,,Docetaxel (Taxotere®)-cisplatin (TC): An effective drug combination in gastric carcinoma,2000,Annals of Oncology,202,10.1023/A:1008342013224,Switzerland,Article,Geneva,1,Journal,2-s2.0-0034154069
Douillard J.Y.,,Irinotecan combined with fluorouracil compared with fluorouracil alone. as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial,2000,Lancet,2840,10.1016/S0140-6736(00)02034-1,France,Article,Saint-Herblain,0,Journal,2-s2.0-0034712536
Vanhoefer U.,,"Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the european organization for research and treatment of cancer gastrointestinal tract cancer cooperative group",2000,Journal of Clinical Oncology,490,10.1200/JCO.2000.18.14.2648,Germany,Article,Essen,0,Journal,2-s2.0-0033909505
de Gramont A.,,Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer,2000,Journal of Clinical Oncology,3301,10.1200/JCO.2000.18.16.2938,United Kingdom,Article,Leeds,0,Journal,2-s2.0-0033874892
Waters J.S.,,"Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: Results of a randomized trial",1999,British Journal of Cancer,262,10.1038/sj.bjc.6690350,United Kingdom,Article,Sutton,1,Journal,2-s2.0-0032921628
Mai M.,,A late phase II clinical study of RP56976 (docetaxel) in patients with advanced or recurrent gastric cancer: a cooperative study group trial (group B),1999,Gan to kagaku ryoho. Cancer &amp; chemotherapy,76,,Japan,Article,Kanazawa,0,Journal,2-s2.0-2342465869
Glimelius B.,,Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer,1997,Annals of Oncology,685,10.1023/A:1008243606668,Sweden,Article,Uppsala,1,Journal,2-s2.0-8044236424
Webb A.,,"Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer",1997,Journal of Clinical Oncology,818,10.1200/JCO.1997.15.1.261,United Kingdom,Article,Sutton,0,Journal,2-s2.0-0031022803
Einzig A.,,Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: The Eastern Cooperative Oncology Group (ECOG) results of protocol E1293,1996,Medical Oncology,183,10.1007/BF02993858,United States;United States,Article,New York;New York,0,Journal,2-s2.0-0030451795
Pyrhönen S.,,"Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer",1995,British Journal of Cancer,733,10.1038/bjc.1995.114,Finland,Article,Helsinki,1,Journal,2-s2.0-0028959887
Sulkes A.,,Docetaxel (Taxotere™) in advanced gastric cancer: Results of a phase II clinical trial. EORTC Early Clinical Trials Group,1994,British Journal of Cancer,232,10.1038/bjc.1994.310,Israel,Article,Petah Tiqwa,1,Journal,2-s2.0-0028487470
Aaronson N.,,The European organization for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology,1993,Journal of the National Cancer Institute,8694,10.1093/jnci/85.5.365,Netherlands,Article,Amsterdam,0,Journal,2-s2.0-0027417437
Murad A.M.,,"Modified therapy with 5‐fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer",1993,Cancer,681,10.1002/1097-0142(19930701)72:1<37::AID-CNCR2820720109>3.0.CO;2-P,Brazil,Article,Belo Horizonte,1,Journal,2-s2.0-0027217474
Miller A.,,Reporting results of cancer treatment,1981,Cancer,7013,10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6,Belgium,Article,Brussels,1,Journal,2-s2.0-0019365237
